Skip to main content
SpringerLink
Log in

Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry

  • Original Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

A metabonomics technique based on ultra-performance liquid chromatography (UPLC) coupled with Q-TOF mass spectrometry was employed to investigate the sera from 32 patients with chronic renal failure (CRF) without renal replacement therapy and 30 healthy volunteers in order to find potential disease biomarkers and reveal its pathophysiological changes. After data acquisition Waters MarkerLynx software was used to report retention time and m/z pairs for each metabolite peak, these data were exported to an excel table, then handled by using multivariate analysis and the statistical analysis in the SIMCA-P and the SPSS softwares to obtain potential biomarkers which were further identified by MS/MS. Seven potential biomarkers, creatinine, tryptophan, phenylalanine, kynurenine and three lysophosphatidylcholines, were identified. The results suggest that CRF can lead to the increase of reservation of creatinine in the body, and the abnormal metabolism of the two essential amino acids and lysophosphatidylcholines. It has indicated that metabonomics will be a powerful tool in the clinic research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Bergstrom, J., Alvestrand, A., & Furst, P. (1990). Plasma and muscle free amino acid in maintenance hemodialysis patients without protein malnutrition. Kidney International, 38(1), 108–109.

    Article  PubMed  CAS  Google Scholar 

  • Collins, A. J., Kasiske, B., Herzog, C., Chavers, B., Foley, R., Gilbertson, D., Grimm, R., Liu, J., & Louis, T. (2005). Excepts from the United States renal data system 2004 annual data report: Atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases, 45(suppl), A5–A7.

    Article  PubMed  Google Scholar 

  • Constantinou, M. A., Papakonstantinou, E., & Spraul, M. (2005). 1H NMR-based metabonomics for the diagnosis of inborn errors of metabolism in urine. Analytica Chimica Acta, 511, 303–312.

    Article  Google Scholar 

  • Coresh, J., Astor, B. C., & Greene, T. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult US population: The third National Health and Nutrition Examination survey. American Journal of Kidney Diseases, 41, 1–12.

    Article  PubMed  Google Scholar 

  • Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005). Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. Journal of the American Society of Nephrology, 16, 180–188.

    Article  PubMed  Google Scholar 

  • Desmond, O., & Russell, M.-S. (2006). High-throughput bioanalysis with simultaneous acquisition of metabolic route data using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry, 385(1), 114–121.

    Article  Google Scholar 

  • Dunn, W. B., Broadhurst, D. I., Deepak, S. M., Buch, M. H., McDowell, G., Spasic I., Ellis, D. I., Brooks, N., Kell, D. B., & Neyses L. (2007). Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics, 3, 413–426.

    Article  CAS  Google Scholar 

  • Duong, C. Q., Bared, S. M., Abu-Khader, A., Buechler, C., Schmitz, A., & Schmitz, G. (2004). Expression of the lysophopholipid receptor family and investigation of lysophopholipid-mediated responses in human macrophages. Biochimica et Biophysica Acta, 1682, 112–119.

    PubMed  CAS  Google Scholar 

  • Eggers, P. W. (1999). Clinical aspects for which treatment with the artificial kidney to be considered. In R. A. Petting & N. G. Levinsky (Eds.), Kidney failure and the federal government (82 pp). Washington, DC: National Academy Press.

    Google Scholar 

  • Frank, R., & Hargreaves, R. (2003). Clinical biomarkers in drug discovery and development. Nature Reviews Drug Discovery, 2, 566–580.

    Article  PubMed  CAS  Google Scholar 

  • Gillett, M.-P. T., Obineche, E. N., Lakhani, M. S., Abdulle, A. M., Amirlak, I., Rukhaimi, M. A., & Suleiman, M. N. (2001). Levels of cholesteryl esters and other lipids in the plasma of patients with end-stage renal failure. Annals of Saudi Medicine, 21, 283–286.

    PubMed  CAS  Google Scholar 

  • Johnson, K. A., & Plumb, R. (2005). Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS. Journal of Pharmaceutical and Biomedical Analysis, 39, 805–810.

    Article  PubMed  CAS  Google Scholar 

  • Jones, M. R., Kopple, J. D., & Swendseid, M. E. (1978). Phenylalanine metabolism in uremia and normal man. Kidney International, 14(2), 169.

    Article  PubMed  CAS  Google Scholar 

  • Keun, H. C., Beckonert, O., Griffin, J. L., Richter, C., Moskau, D., Lindon, J. C., & Nicholson, J. K. (2002). Cryogenic probe C-13NMR spectroscopy of urine for metabonomic studies. Analytical Chemistry, 74, 4588–4593.

    Article  PubMed  CAS  Google Scholar 

  • Khandelwal, P., Beyer, C. E., Lin, Q., McGonigle, P., Schechter, L. E., & Bach, A. C. (2004). Nanoprobe NMR spectroscopy and in vivo microdialysis: New analytical methods to study brain neurochemistry. Journal of Neuroscience Methods, 133, 181–189.

    Article  PubMed  CAS  Google Scholar 

  • Kuhara, T. (2005). Gas chromatographic-mass spectrometric urinary metabolome analysis to study mutations of inborn errors of metabolism. Mass Spectrometry Reviews, 24(6), 814–827.

    Article  PubMed  CAS  Google Scholar 

  • Locatelli, F., Del Vecchio, L., Pozzoni, P., & Manzoni, C. (2006). Nephrology: Main advance in the last 40 years. Journal of Nephrology, 19, 6–11.

    PubMed  Google Scholar 

  • Monique, P., Christine, V.-S., Konstantinos, P., Claire, E., Jean-Paul, S., Aymeric, M., & Denis, B. (2003). ESI-MS/MS analysis of underivatised amino acids: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Fragmentation study of 79 molecules of biological interest in positive and negative ionization mode. Rapid Communications in Mass Spectrometry, 17, 1297–1331.

    Article  Google Scholar 

  • Morita, T., Saito, K., & Takemura, M. (2001). 3-Hydroxyanthranilic acid, an l-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma. Annals of Clinical Biochemistry, 38(pt3), 242–251.

    Article  PubMed  CAS  Google Scholar 

  • Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002). Metabonomics: A platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery, 1(2), 153–162.

    Article  PubMed  CAS  Google Scholar 

  • Nicholson, J. K., Holmes, E., Lindon, J. C., & Wilson, I. D. (2004). The challenges of modeling mammalian biocomplexity. Nature Biotechnology, 22(10), 1268–1274.

    Article  PubMed  CAS  Google Scholar 

  • Oestvang, J., & Johansen, B. (2006). Phospholipase A2: A key regulator of inflammatory signaling and a connector to fibrosis development in atherosclerosis. Biochimica Biophysica Acta, 1761, 1309–1316.

    CAS  Google Scholar 

  • Pawlak, D., Pawlak, K., Malyszko, J., Mysliwiec, M., & Buczko, W. (2001). Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. International Urology and Nephrology, 33(2), 399–404.

    Article  PubMed  CAS  Google Scholar 

  • Pawlak, D., Tankiewicz, A., Myslwiec, P., & Buczko, W. (2002). Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure. Nephron, 90(3), 328–335.

    Article  PubMed  CAS  Google Scholar 

  • Plumb, R. S., Granger, J. H., & Stumpf, C. L. (2005). A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: Application to age, gender,and diurnal variation in normal/Zucker obese rats and black, white, and nude mice. Analyst, 130(6), 844–849.

    Article  PubMed  CAS  Google Scholar 

  • Pognan, F. (2004). Genomics, proteomics and metabonomics in toxicology: Hopefully not ‘fashionomics’. Pharmacogenomics, 5(7), 879–893.

    Article  PubMed  CAS  Google Scholar 

  • Saito, K., Fujigaki, S., & Heyes, M. P. (2000). Mechanism of increased in l-kynurenine and quinolinic acid in renal insufficiency. American Journal of Physiology Renal Physiology, 279(2), F565–F572.

    PubMed  CAS  Google Scholar 

  • Van der Greef, J., Davidov, E., Verheij, E. R., Vogels, J., Van der Heijden, R., Adourian, A. S., Oresic, M., Marple, E. W., & Naylor, S. (2003). The role of metabolomics in system biology. In G. G. Harrigan & R. Goodacre (Eds.), Metabolic profiling: Its role in biomarker discovery and gene function analysis (pp. 170–198). Boston, Dordrecht, London: Kluwer Academic Publishers.

    Google Scholar 

  • Van der Greef, J., Stroobant, P., & Van der Heijden, R. (2004). The role of analytical sciences in medical systems biology. Current Opinion in Chemical Biology, 8, 559–565.

    Article  PubMed  Google Scholar 

  • Wang, C., Yang, J., Gao, P., Li, X., & Xu, G. W. (2005). Identification of phospholipids structures in human blood by direct-injection quadrupole-linear ion-trap mass spectrometry. Rapid Communications in Mass Spectrometry, 19, 2443–2453.

    Article  PubMed  CAS  Google Scholar 

  • Want, E. J., Smith. C. A., Qin, C., Vanhorne, K. C., & Siuzdak, G. (2006). Phospholipid captune combined with non-linear chromatographic correction for improved serum metabolite profiling. Metabolomics, 2(2), 95–104.

    Article  Google Scholar 

  • Wilson, I. D., Nicholson, J. K., Castro-Perez, J., Granger, J. H., Johnson, K. A., Smith, B. W., & Plumb, R. S. (2005). High resolution “Ultra performance” liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. Journal of Proteome Research, 4, 591–598.

    Article  PubMed  CAS  Google Scholar 

  • Xu, Y., Xiao, Y. J., Zhu, K., Baudhuin, L. M., Lu, J., Hong, G., Kim, K. S., Cristina, K. L., Song, L., & William, F. S. (2003). Unfolding the pathophysiological role bioactive lysophospholipids. Current Drug Targets, 3(1), 23–32.

    PubMed  CAS  Google Scholar 

  • Xue, J. L., Ma, J. Z., Louis, T. A., & Collins, A. J. (2001). Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. Journal of the American Society of Nephrology, 12, 2753–2758.

    PubMed  CAS  Google Scholar 

  • Yang, J., Zhao, X. J., Liu, X. L., Wang, C., Gao, P., Wang, J. S., Li, L. J., Gu, J. R., Yang, S. L., & Xu, G. W. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research, 5, 554–561.

    Article  PubMed  CAS  Google Scholar 

  • Yin, P. Y., Zhao, X. J., Ki, Q. R., Wang, J. S., Li, J. S., & Xu, G. W. (2006). Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). Journal of Proteome Research, 5, 2135–2143.

    Article  PubMed  CAS  Google Scholar 

  • Zoccali, C. (2006). Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney International, 70, 26–33.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The study has been supported by the foundation (No. 20425516) for Distinguished Young Scholars and the foundation (No. 20675082) from National Natural Science Foundation of China, and National Basic Research Program of China (2006CB503902).

Author information

Authors and Affiliations

  1. National Chromatographic R&A Center, Dalian Institute of Chemical Physics, The Chinese Academy of Sciences, Dalian, 116023, China

    Lewen Jia, Jing Chen, Peiyuan Yin, Xin Lu & Guowang Xu

  2. Department of Nephrology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China

    Lewen Jia

Authors
  1. Lewen Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peiyuan Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guowang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guowang Xu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jia, L., Chen, J., Yin, P. et al. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4, 183–189 (2008). https://doi.org/10.1007/s11306-008-0110-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11306-008-0110-x

Keywords

Search

Navigation